AOD-9604
RestrictedFat-Metabolism Peptide
Based on public FDA bulk-substance and shortage listings, it appears to be off the permitted bulk substances list, or a shortage-based exception has ended. That's our read that no established pathway currently applies — not a formal legal bar, and not a determination we're qualified to make. Confirm current status with FDA sources or counsel.
Not legal advice. Every status on this page is our own reading of public FDA guidance, shortage listings, and committee materials — it has not been reviewed by an attorney and is not a legal determination. "Contested" means pharmacies and regulators publicly disagree, not that we're resolving the disagreement. Verify independently, and check with counsel, before relying on any entry here.
Current status
A fragment of human growth hormone marketed for fat metabolism; never FDA-approved and not on the 503A bulk substances list. Listed among the peptides expected to shift from Category 2 to Category 1 under HHS Secretary Kennedy's February 2026 announcement, but that reclassification has not been formally completed by FDA as of the sources checked here.
Last changed: 2026-04-15